重庆科瑞制药（集团）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
357
NMPA:357
Drug Approvals
Cefoxitin Sodium for Injection
- Product Name
- 注射用头孢西丁钠
- Approval Number
- 国药准字H20053755
- Approval Date
- Nov 5, 2024
NMPA
Cefoxitin Sodium for Injection
- Product Name
- 注射用头孢西丁钠
- Approval Number
- 国药准字H20053756
- Approval Date
- Nov 5, 2024
NMPA
Levofloxacin Hydrochloride Tablets
- Product Name
- 盐酸左氧氟沙星片
- Approval Number
- 国药准字H20094069
- Approval Date
- Sep 30, 2024
NMPA
Vitamins With Minerals Tablets（21）
- Product Name
- 多维元素片(21)
- Approval Number
- 国药准字H20093765
- Approval Date
- Jun 27, 2024
NMPA
Clindamycin Palmitate Hydrochloride Granules
- Product Name
- 盐酸克林霉素棕榈酸酯颗粒
- Approval Number
- 国药准字H20031364
- Approval Date
- Feb 22, 2024
NMPA
Clindamycin Phosphate Gel
- Product Name
- 克林霉素磷酸酯凝胶
- Approval Number
- 国药准字H20083374
- Approval Date
- Apr 21, 2023
NMPA
Compound Ranitidine Tablets
- Product Name
- 复方雷尼替丁片
- Approval Number
- 国药准字H20080323
- Approval Date
- Mar 24, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 36
- Next
Clinical Trials
No trials found
News
No news found